Real-World Effectiveness of Bevacizumab Based on AURELIA in Platinum-resistant Recurrent Ovarian Cancer
Phase of Trial: Phase IV
Latest Information Update: 18 Jan 2019
At a glance
- Drugs Bevacizumab (Primary) ; Doxorubicin liposomal; Paclitaxel; Topotecan
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms REBECA
- 10 Jan 2019 Status changed from active, no longer recruiting to completed.
- 05 Nov 2018 Results published in the Gynecologic Oncology
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology.